A study demonstrated that verbascoside had potential therapeutic value for Parkinson’s disease by activating the nuclear factor erythroid 2-related factor/anti-oxidation reaction element (Nrf2/ARE) signaling pathway (54). Here, NFE2L2 is linked to Parkinson disease.